India revisits its decision, grants hepatitis C drug patent to Gilead
Gilead said the goal of its voluntary licensing programme, and "partnership" with Indian manufacturers, is to enable access to medicines for as many people as possible, as quickly as possible.
Gandhinagar: Union Minister for Health and Family Welfare J.P. Nadda addresses at the 43rd Annual National Conference of Preventive and Social Medicine (IAPSMCON 2016), at Gandhinagar, in Gujarat on Jan 7, 2016. (Photo: IANS/PIB)